Since that definition, multiple observations indicate that MSI-L is most often seen with frameshift mutation among dinucleotide repeats, a lack of association with MSH6 mutation or loss [15], a lack of association with MSH2 or MLH1 loss, an association with inflammation, and is observed among EMAST cancers [16,17]. The gene discussed is MLH1; the disease is cancer.